Page-2 of Pharma sector
Government constitute committee to make drugs more affordable
The Union Ministry of Chemicals and Fertilisers has constituted a committee of joint secretaries for ensuring enhanced affordability, availability and accessibility of drugs for the citizens. The committee will suggest ways to make pricing policy in favour of poor patients. ..
Month: Current Affairs - August, 2017
NRAI gets highest WHO ratings for vaccine regulations
India’s vaccine regulatory body NRAI (National Regulatory Authority of India) was given the maximum ratings by the World Health Organisation (WHO) for vaccine regulations. The ratings were given by WHO after completing the assessment of the status of the NRAI ..
Month: Current Affairs - February, 2017
DTAB suggests one-time licensing for drugs
The Drugs Technical Advisory Board (DTAB) recently recommended one-time licensing for manufacture and sales of drugs. If the recommendation is approved it will change present of the renewal of licences for each formulation which rests with state regulators and takes ..
Month: Current Affairs - December, 2016
Delhi High Court reverses ban on fixed dose combination drugs
The Delhi High Court has quashed ban imposed on 344 fixed dose combination (FDC) drugs by the Central Government over fears that they are potential health and safety hazards. The HC held that Centre had acted in a haphazard manner ..
Month: Current Affairs - December, 2016
WHO settles India, EU medicine dispute issue
The World Health Organisation (WHO) has dropped the term ‘counterfeit’ and retained ‘falsified’ to describe medicines of inferior quality. This decision was taken by a WHO’s technical working group on draft working definitions of substandard/spurious /falsely-labelled/falsified/counterfeit (SSFFC) medical products. It ..
Month: Current Affairs - November, 2016
Indian Pharma companies rank 19th in Biopharmaceutical Competitiveness & Investment (BCI) Survey
Indian pharmaceutical companies have ranked low at 19th position with an overall score of 59 out of 100 among in the Biopharmaceutical Competitiveness & Investment (BCI) Survey. The survey of 28 countries was commissioned by the Pharmaceutical Research and Manufacturers ..